ONCOGENE TRANSFORMATION FREQUENCY OF NONSENESCENT SFME CELLS IS INCREASED BY C-MYC

被引:0
|
作者
RAWSON, C [1 ]
SHIRAHATA, S [1 ]
COLLODI, P [1 ]
NATSUNO, T [1 ]
BARNES, D [1 ]
机构
[1] OREGON STATE UNIV,ENVIRONM HLTH SCI CTR,DEPT BIOCHEM & BIOPHYS,CORVALLIS,OR 97331
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immortalized, postcrisis mouse embryo cell cultures derived in serum-containing medium display genomic abnormalities and an altered, preneoplastic phenotype. These lines can be transformed with single oncogenes, such as Ha-ras, while efficient transformation of precrisis, genomically unaltered rodent embryo cultures require cooperating oncogenes, such as Ha-ras and the mouse c-myc gene constitutively expressed. Serum-free mouse embryo (SFME) cells, cultured under conditions in which serum is replaced by growth factors and other supplements, are 'immortalized' in the genomically unaltered state. SFME cells do not exhibit growth crisis or gross chromosomal aberration, and are dependent on epidermal growth factor for survival, growth inhibited by serum, and are nontumorigenic. Transformation of SFME cells can be achieved with ras alone, but the introduction of c-myc increased the transfection frequency upon subsequent transfection with ras by as much as twenty fold. Similar results were obtained with mutationally activated neu oncogene and with genomic human tumor DNA. Constitutive expression of c-myc alone did not alter the properties of the SFME cells. These results demonstrate that c-myc alters cellular responses to oncogenes in a culture system in which oncogene-induced immortalization is not a factor, indicating that the effects of myc may extend beyond an 'immortalization' function in these cells.
引用
收藏
页码:487 / 489
页数:3
相关论文
共 50 条
  • [21] Chrysotile-induced cell transformation and transcriptional changes of c-myc oncogene in human embryo lung cells
    Fan, JG
    Wang, QE
    Liu, SJ
    BIOMEDICAL AND ENVIRONMENTAL SCIENCES, 2000, 13 (03) : 163 - 169
  • [22] SUPPRESSION OF THE NORMAL MOUSE C-MYC ONCOGENE IN HUMAN LYMPHOMA-CELLS
    FEO, S
    ARRUSHDI, A
    HUEBNER, K
    FINAN, J
    NOWELL, PC
    CLARKSON, B
    CROCE, CM
    NATURE, 1985, 313 (6002) : 493 - 495
  • [23] IDENTIFICATION OF THE C-MYC ONCOGENE PRODUCT IN NORMAL AND MALIGNANT B-CELLS
    GIALLONGO, A
    APPELLA, E
    RICCIARDI, R
    ROVERA, G
    CROCE, CM
    SCIENCE, 1983, 222 (4622) : 430 - 432
  • [24] STRUCTURE AND EXPRESSION OF THE C-MYC ONCOGENE IN MORTAL AND IMMORTAL, UNTRANSFORMED RODENT CELLS
    TAVASSOLI, M
    SHALL, S
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (11): : 1803 - 1804
  • [25] DINUCLEOTIDE REPEAT POLYMORPHISM AT THE HUMAN C-MYC ONCOGENE LOCUS (MYC)
    POLYMEROPOULOS, MH
    XIAO, H
    MERRIL, CR
    HUMAN MOLECULAR GENETICS, 1992, 1 (01) : 65 - 65
  • [26] HELATG CELLS HAVE MITOCHONDRIAL-DNA INSERTED INTO THE C-MYC ONCOGENE
    SHAY, JW
    BABA, TO
    ZHAN, QM
    KAMIMURA, N
    CUTHBERT, JA
    ONCOGENE, 1991, 6 (10) : 1869 - 1874
  • [27] AMPLIFICATION AND EXPRESSION OF A CELLULAR ONCOGENE (C-MYC) IN HUMAN GASTRIC ADENOCARCINOMA CELLS
    SHIBUYA, M
    YOKOTA, J
    UEYAMA, Y
    MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (02) : 414 - 418
  • [28] REGULATION OF THE C-MYC ONCOGENE DURING DIFFERENTIATION OF HL60 CELLS
    SIEBENLIST, U
    BRESSLER, P
    KELLY, K
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 159 - 159
  • [29] Identification of Zfp161 as a regulator of the c-Myc oncogene in human cells
    Feng, Y.
    Tu, X.
    Kim, W.
    Lou, Z.
    ANNALS OF ONCOLOGY, 2020, 31 : S251 - S252
  • [30] Infrequent alteration of the c-myc gene in human glial tumours associated with increased numbers of c-myc positive cells
    Chattopadhyay, P
    Banerjee, M
    Sarkar, C
    Mathur, M
    Mohapatra, AK
    Sinha, S
    ONCOGENE, 1995, 11 (12) : 2711 - 2714